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Abstract
Background: Patients discharged home after stroke face significant challenges managing residual neurological deficits,
secondary prevention, and pre-existing chronic conditions. Post-discharge care is often fragmented leading to
increased healthcare costs, readmissions, and sub-optimal utilization of rehabilitation and community services. The
COMprehensive Post-Acute Stroke Services (COMPASS) Study is an ongoing cluster-randomized pragmatic trial to
assess the effectiveness of a comprehensive, evidence-based, post-acute care model on patient-centered outcomes.
Methods: Forty-one hospitals in North Carolina were randomized (as 40 units) to either implement the COMPASS care
model or continue their usual care. The recruitment goal is 6000 patients (3000 per arm). Hospital staff ascertain and
enroll patients discharged home with a clinical diagnosis of stroke or transient ischemic attack. Patients discharged
from intervention hospitals receive 2-day telephone follow-up; a comprehensive clinic visit within 2 weeks that
includes a neurological evaluation, assessments of social and functional determinants of health, and an individualized
COMPASS Care Plan™ integrated with a community-specific resource database; and additional follow-up calls at 30 and
60 days post-stroke discharge. This model is consistent with the Centers for Medicare and Medicaid Services
transitional care management services provided by physicians or advanced practice providers with support from a
nurse to conduct patient assessments and coordinate follow-up services. Patients discharged from usual care hospitals
represent the control group and receive the standard of care in place at that hospital. Patient-centered outcomes are
collected from telephone surveys administered at 90 days. The primary endpoint is patient-reported functional status
as measured by the Stroke Impact Scale 16. Secondary outcomes are: caregiver strain, all-cause readmissions, mortality,
healthcare utilization, and medication adherence. The study engages patients, caregivers, and other stakeholders
(including policymakers, advocacy groups, payers, and local community coalitions) to advise and support the design,
implementation, and sustainability of the COMPASS care model.
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Discussion: Given the high societal and economic burden of stroke, identifying a care model to improve recovery,
independence, and quality of life is critical for stroke survivors and their caregivers. The pragmatic trial design provides
a real-world assessment of the COMPASS care model effectiveness and will facilitate rapid implementation into clinical
practice if successful.
Trial registration: Clinicaltrials.gov: NCT02588664; October 23, 2015.
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Background
Stroke is a major cause of long-term disability and mor-
tality in the United States, exemplifying a complex
chronic disease with high co-morbidity, associated
healthcare costs, and readmission rates [1–6]. An esti-
mated 6.6 million Americans aged 20 years and older
have had a stroke, and each year approximately 795,000
people experience a new or recurrent stroke [5]. North
Carolina (NC) has a particularly high stroke burden and
is in the geographic region of the country known as the
‘Stroke Belt’. Stroke mortality in Eastern NC is 40%
higher than the national average and hospital admission
rates are the highest in the state [7]. African Americans
comprise over 20% of the NC population and are more
likely to be affected by stroke than their white counter-
parts, such as having higher post-stroke hospital re-
admission rates [5, 7, 8].
Stroke survivors experience significant physical, men-
tal and social challenges. Roughly half are discharged
directly home from the hospital, where they often realize
disabilities not identified during hospitalization and are
at risk for complications such as falls, physical decondi-
tioning, aspiration pneumonia, infections, social isola-
tion and depression as well as recurrent stroke [4, 9–16].
Patients with mild post-stroke disability often have un-
detected physical and cognitive deficits that interfere
with function and management of risk factors and
medication [17, 18]. Individuals discharged with a
clinical diagnosis of transient ischemic attack (TIA) may
also have residual deficits and are at increased risk for
future stroke [19–21].
Family members who care for stroke survivors often
face significant burden [22–24]. Approximately 70% of
stroke survivors require assistance with activities of daily
living [5]. This assistance is usually provided by family
members who are often unprepared and ill-equipped to
assume caregiving responsibilities such as providing
direct care (e.g., bathing, toileting, mobility assistance,
transfers), managing medications, assisting with instru-
mental activities of daily living, managing stroke survivor
emotions and behaviors, communicating with providers,
and identifying and accessing community resources.
These new responsibilities often lead to overwhelming
physical and emotional strain, depressive symptoms,
decline in physical and mental health, reduced quality of
life, and isolation in the family caregiver [23, 25].
An effective, post-acute care model is needed given
the significant impact of stroke on public health, the
high risk and complexity of these patients early after dis-
charge, and the strain on caregivers [26, 27]. Currently
the U.S. lacks a standard to require hospitals to coordin-
ate community-based follow-up visits with primary or
specialty care [26]. The variation in availability, access,
referrals, and effectiveness of post-acute stroke medical
and rehabilitative care leads to significant gaps in the
stroke system of care [28]. These gaps can lead to
increased likelihood of readmission, and thus higher
healthcare costs. Improved transitions of care from the
acute phase to the post-discharge environment may help
improve functional status and quality of life for stroke
survivors and their caregivers and reduce healthcare
costs to society [27]. Stroke morbidity and mortality may
also be reduced through effective transitional care, second-
ary prevention, and rehabilitation early post-stroke [29–33].
Early supported discharge (ESD) is the only evidence-
based transitional care intervention found to reduce the
negative impact of stroke (i.e., decreased length of stay,
accelerated functional recovery, improved patient and
caregiver satisfaction) and is the standard of care in the
United Kingdom and Canada [24, 31, 34–37]. ESD uti-
lizes a hospital-based, multidisciplinary team of physi-
cians, nurses, therapists, and social workers with stroke
expertise to decrease length of stay, anticipate, prevent,
and manage stroke complications, improve functional
status, and optimize stroke risk factor management, all
without increasing caregiver burden [24]. ESD has not
been evaluated in the U.S. or non-urban settings and
few of its components are in place at 29 stakeholder NC
hospitals we surveyed [38].
Our goal was to develop, implement, and evaluate a
comprehensive, evidence-based, post-acute care model
in real-world practice. Our care model uses elements of
transitional care management and ESD evaluated in our
prior work with the TRAnsition Coaching for Stroke
(TRACS) model that demonstrated reduced readmis-
sions [39]. The intervention was designed to be consist-
ent with the Centers for Medicare and Medicaid
Services (CMS) care and reimbursement models for
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transitional care management [40]. We engaged a range
of stakeholders from patients to policy makers, with the
goal of making the intervention patient-centered, useful
to providers, and lead to greater uptake of results by the
larger medical community.
Study aims
The COMPASS Study was designed to compare the
COMPASS care model versus usual post-discharge care
on stroke survivors’ self-reported functional status (Stroke
Impact Scale-16) 90 days post-stroke hospital discharge.
Secondary aims were to determine if the COMPASS care
model reduces: i) caregiver strain 90 days post-stroke
discharge; ii) all-cause 30- and 90-day readmissions; iii)
mortality, health care use (emergency department visits,
all-cause re-hospitalization, admission to skilled nursing
facilities, admission to inpatient rehabilitation facilities) up
to one year after stroke hospitalization; and iv) medication
non-adherence.
Methods
Objective & study design
The study objective was to evaluate the effectiveness of
the COMPASS care model against usual care in diverse
hospital settings and patients under real-world clinical
conditions. We utilized a cluster-randomized pragmatic
trial design in which the unit of randomization was the
hospital. This design was chosen as it provides a real-
world assessment of our new care model versus usual
care. Our design also facilitates rapid dissemination and
uptake of successful care strategies and helps health sys-
tems prepare for CMS value-based care models [40–43].
Hospital recruitment
Hospitals eligible to participate in the COMPASS Study
included those that 1) were located in North Carolina; 2)
had an emergency department; 3) treated stroke
patients; and 4) were able to identify stroke and TIA
patients concurrent with care. Recruitment efforts first
targeted hospitals in the NC Stroke Care Collaborative
(NCSCC) network (N = 51) [4]. The NCSCC is a
hospital-based, prospective registry of stroke patients
and was part of the Centers for Disease Control and
Prevention’s Paul Coverdell National Acute Stroke
Registry Program through 2014 [4]. It was designed to
measure, track, and improve the quality of acute stroke
care. The NCSCC hospital network covers 60% of the
counties in NC, 80% of the state’s population, and 82%
of stroke discharges annually. Recruitment efforts were
next extended to all other eligible hospitals in NC.
Hospital recruitment lasted for 1 year by which time a
total of 110 hospitals in NC had been identified as po-
tentially eligible and invited to participate. Fifteen hospi-
tals did not meet one or more of the inclusion criteria
(Fig. 1) because they transferred all stroke patients from
the emergency department to another hospital. In
addition, 54 hospitals declined to participate in the
study. Limited resources (e.g., finances, staff, time) ne-
cessary to establish the COMPASS clinic infrastructure
and adopt the intervention care model was the primary
reason given for non-participation.
Forty-one hospitals (40 randomized units) agreed to
participate in the COMPASS study (Fig. 1). Two hospi-
tals were paired as a single randomization unit because
their degree of shared staff would have compromised the
integrity of independent randomization. Participating
hospitals are distributed across urban and rural regions
of the state as well as across the three geographic re-
gions of NC, with the majority located in the central
Piedmont region (Table 1; Fig. 2) where much of the
state’s population resides. Twenty-three sites were Joint
Commission certified as a primary or comprehensive
stroke center at the time of randomization and 30% had
high annual stroke volumes.
Randomization
Hospitals were randomized to either receive the COMPASS
care model or maintain their usual care. We used a
stratified cluster-randomized approach with a block size
of two, which maintained balance between treatment
groups while also protecting the validity of the
randomization process. Only pairs of hospitals were
randomized until the end of the study when two hospi-
tals without matches were randomized individually.
Hospitals were assigned to one of four strata defined by
stroke patient discharge volume and primary stroke
center (PSC) certification status (PSC/high-volume;
PSC/low-volume; non-PSC/high-volume; non-PSC/low-
volume). The study team involved with site selection
(RD, SJ) did not have access to the randomization
schedule, which was held by a biostatistician (WA) who
performed all randomizations and was not involved in
site selection. Randomization continued in three waves
from April, 2016 through January 2017.
A central IRB was established by Wake Forest University
to facilitate oversight of study activities across the 41
participating hospitals. This IRB reviewed and approved
the study protocol including the unique aspects of patient
consent in this pragmatic trial, discussed later in this paper.
The study period for analysis of the primary and
secondary aims (Phase 1) will last until accrual of 6000
participants. At the close of Phase 1, hospitals random-
ized to usual care will receive the COMPASS care
model while hospitals randomized to COMPASS care
model in Phase 1 will sustain the model with their own
resources (Phase 2). This delayed-start study design
allows all enrolled hospitals to eventually receive the
intervention [44].
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Participant inclusion & exclusion criteria
The COMPASS Study will enroll 6000 stroke patients
discharged home from participating hospitals in Phase
1 (3000 each per randomization arm over ~1 year)
and an additional 6000 patients in Phase 2. Patient
enrollment began after each hospital was randomized
and trained. Eight sites began enrollment in July,
2016, 10 between October–November 2016, and 22
from December 2016–March 2017. Patient eligibility
criteria, selected to maximize external validity, are as
follows:
(1)Aged 18 years of age or older
(2)English or Spanish speaker
(3)Diagnosed with ischemic stroke, hemorrhagic stroke
(excluding subdural or aneurysmal hemorrhage), or
TIA; excluding elective carotid endarterectomy
procedures
(4)Discharged to home (excludes discharges to prison,
nursing home, inpatient rehabilitation facility,
hospice and comfort measures only)
Hospital staff use a clinical algorithm with standard-
ized definitions for stroke and TIA diagnosis (Additional
file 1). Ischemic stroke requires persistence of symptoms
for at least 1 h and at least 1 of the following: MRI
confirmation of infarct or ischemia, receipt of tPA with or
without confirmation on MRI, or high suspicion of
cerebrovascular etiology if MRI was negative. Non-
traumatic intra-parenchymal hemorrhage requires persist-
ence of symptoms >1 h and CT/MRI evidence of
hemorrhage. TIA is defined as a transient episode of neuro-
logical dysfunction caused by focal brain, spinal cord, or
retinal ischemia without acute infarction. Specifically, TIA
diagnosis requires symptoms >5 min in duration with MRI
finding negative for acute infarct and absence of suspected
stroke mimics (i.e., syncope, complicated migraine, infec-
tion, reactivation of old stroke symptoms, delirium, medica-
tion reaction, intoxication, angina, and seizure).
Case ascertainment
Clinical or administrative nursing staff ascertain pre-
sumptive stroke and TIA patients concurrently with care
Fig. 1 Hospital recruitment and randomization. *Reasons are not mutually exclusive. “Other” reasons include: Decision made at the health system
level; bureaucratic issues; decision maker(s) unconvinced of additive value of participation; concerns about sustainability, who should be the
on-site principal investigator, and/or IRB/consenting
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Table 1 Characteristics of randomized hospital units in the COMPASS Study
Total (N = 40) Intervention (N = 20) Usual care (N = 20)
Joint Commission certified stroke center, n (%) 23 (58%) 12 (60%) 11 (55%)
Critical Access Hospital, n (%) 5 (13%) 3 (15%) 2 (10%)
Geographic region, n (%)
Piedmont 17 (43%) 9 (45%) 8 (40%)
Western 11 (28%) 6 (30%) 5 (25%)
Eastern 12 (30%) 5 (25%) 7 (35%)
Medical school affiliation, n (%)
Major 3 (8%) 1 (5%) 2 (10%)
Graduate or limited 5 (12%) 2 (10%) 3 (15%)
None 32 (80%) 17 (85%) 15 (75%)
Annual stroke volume, n (%)
< 100 discharges 11 (28%) 5 (25%) 5 (25%)
100–299 discharges 17 (43%) 9 (45%) 9 (45%)
300+ discharges 12 (30%) 6 (30%) 6 (30%)
Hospital bed size, n (%)
< 100 beds 15 (38%) 8 (40%) 7 (35%)
100–300 beds 15 (38%) 6 (30%) 9 (45%)
≥ 300 beds 10 (25%) 6 (30%) 4 (20%)
Urban-rural classification, n (%)
Rural/Small town 4 (10%) 3 (15%) 1 (5%)
Micropolitan 15 (38%) 8 (40%) 7 (35%)
Metropolitan 21 (53%) 9 (45%) 12 (60%)
30-day Rate for stroke patients, median (IQR)
Mortality 15.5 (14.2–16.5) 15.6 (13.9–16.6) 15.2 (14.2–16.4)
Readmissions 12.8 (12.2–13.7) 12.8 (12.1–13.9) 12.8 (12.4–13.8)
CMS HCAHPS* 5-Star Quality Rating, median (IQR)
Overall summary score 3 (3–4) 3 (3–4) 3 (3–4)
Care transition score 3 (3–4) 3 (3–4) 3 (3–4)
*Centers for Medicare and Medicaid Services Hospital Consumer Assessment of Healthcare Providers and Systems
Fig. 2 COMPASS Study participating hospitals in North Carolina
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by generating a daily list. They query hospital admissions,
neurology consults, emergency department logs, and obser-
vation units for stroke-related ICD codes and symptoms.
Ascertained patients are followed concurrently with care
and eligibility is determined using a brief form and clinical
algorithm. Patients discharged on a weekend or holiday
may be ascertained on the following business day and en-
rolled retrospectively. The study team performs periodic
case ascertainment audits to compare study enrollment
against hospital discharge lists.
Participant enrollment & retention
Designated hospital staff (post-acute coordinator [PAC] at
an intervention site or stroke care coordinator at a control
site) visit eligible patients prior to discharge. They notify
the patient of the hospital’s participation in the COMPASS
Study and distribute a study information packet that in-
cludes a blood pressure log and site-specific informational
brochure describing the hospital’s post-acute care and the
COMPASS Study. The brochure also explains the voluntary
survey call scheduled for 90 days post-discharge. Hospitals
in the COMPASS care model intervention arm also distrib-
ute additional information (e.g., individualized risk factor
information sheets, refrigerator magnet, business card and
contact phone number for the PAC, and an appointment
for the COMPASS clinic visit.). Reminder letters are mailed
to all participants at 30, 60, and 80 days post-discharge de-
scribing the study purpose, available resources for stroke
survivor and caregivers, and contact information for study
staff. The letter at 30 days includes a COMPASS logo mag-
net and the 80-day letter includes a copy of the 90-day sur-
vey questions to assist with the telephone interview.
Control group: usual care
Hospitals in the control group continue to implement their
current standard of care for stroke patients going home
during Phase 1. The study does not bar hospitals from
implementing changes over the course of the study. In
order to assess transitional care practices prior to the start
of the study, and to monitor changes over time, all COM-
PASS participating hospitals completed a baseline survey.
The survey was administered using an electronic data cap-
ture tool prior to randomization. Information was captured
about the practices and structures in place for care transi-
tions, including availability of telephone and neurology
follow-up, and utilization of Transitional Care Manage-
ment Codes (TCM) billing, post-acute quality metrics, and
outcome assessments. A second survey will be completed
at the close of Phase 1 in order to assess temporal changes
in practice that may have occurred in control sites.
Intervention group: COMPASS care model
The COMPASS care model intervention uses a holistic ap-
proach and integrates medical and community resources
to meet the needs of stroke survivors and caregivers and
optimize outcomes. These needs include medical, physical,
and social determinants of health, goals of care, and pref-
erences as recommended by the CMS. The COMPASS
care model was designed to address these needs by identi-
fying four essential ‘dimensions’ of care to help patients
‘find their way forward after stroke’. These dimensions are
depicted as directions on a compass in messaging to pa-
tient, caregivers, and practitioners (Fig. 3). The COMPASS
care model was developed and refined at the Wake Forest
Baptist Transitional Stroke Clinic (the study vanguard
site). The model consists of patient follow-up post-
discharge and standardized patient and caregiver patient
reported assessments. The innovative focal point of the
COMPASS care model is real-time generation of an indi-
vidualized patient electronic care plan (COMPASS-CP™)
that also incorporates caregiver support needs and an
integrated registry of community resources. The
COMPASS-CP was designed to meet CMS requirements
for comprehensive care of complex patients and was
piloted at the study vanguard site prior to implementation
at trial sites [40]. The development of the individualized
COMPASS-CP was guided by key patient-centered
questions (Table 2) and identifies areas of concern that
prohibit maximizing full recovery and provide a solution
in the form of education, coaching, and referrals to
community-based resources.
The structure and process of the COMPASS care
model are key components of training and implementa-
tion in the setting of this pragmatic clinical trial. The
structural component consists of a team of practitioners
(a registered nurse and an Advanced Practice Provider
[APP; who is a nurse practitioner [45], physician assist-
ant [46], or physician]) identified from existing hospital
staff, usually those who were already involved in stroke
patient clinical care. Their primary functions are to: 1)
establish community resource networks representing
clinical providers, home health agencies, outpatient
therapies, and community agencies; 2) provide input for a
local directory of community resources; 3) utilize TCM
codes during clinic visits [40]; and 4) provide educational
materials focused on helping patients, caregivers and
providers understand stroke recovery and prevention.
The intervention processes are:
1) Telephone follow-up within 2 days of hospital discharge
a. Medication reconciliation
b. Assessment of new stroke symptoms and receipt
of home health or outpatient services
c. Schedule follow-up appointments with PCP and
COMPASS providers
2) Clinic visit within 14 days of discharge during which
the patient/proxy undergoes a series of standardized
assessments (Table 3)
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3) COMPASS-CP development based on the patient’s
individualized needs
4) COMPASS-CP implementation:
a. Coordinate and coach patients to incorporate
recommended strategies across the 4 COMPASS
dimensions of care
b. Make referrals to primary care, specialty care,
rehabilitation services, and community services
c. Communicate with primary care, pharmacy,
home health, and rehabilitation services
5) Telephone follow-up at 30 and 60 days to evaluate
adherence to the COMPASS-CP
The PAC and APP conduct 3 standardized assess-
ments at the clinic visits using an iPad application. Pa-
tient responses are entered into a web-based data-entry
system with a priori defined skip logic. Patient-reported
outcome measures (PROMs) captured as part of these
assessments include, among others, functional and social
determinants of health, cognitive status, health data (e.g.,
blood pressure, medication reconciliation), lifestyle man-
agement (e.g., alcohol, smoking, physical activity), and
knowledge of stroke risk factors (Table 3) [47, 48]. For
patients needing caregiver support, we supplemented the
PROMs with self-reported assessment of the caregiver’s
role in patient self-management and their ability to pro-
vide the necessary support. Algorithms evaluate the data
captured during these assessments and identify factors
that are likely to influence health, recovery and inde-
pendence of the stroke survivor across each dimension
of care (Fig. 4). These are used to generate the
COMPASS-CP, entitled ‘Finding My Way Forward for
Health, Independence, and Recovery’, that is then final-
ized by the APP (Additional file 2). A printed copy of
the COMPASS-CP is provided to each patient and is
available electronically to the patient and all providers
who manage the patient.
Implementation monitoring and evaluation
As part of the pragmatic trial we are monitoring interven-
tion fidelity and have developed a set of post-acute quality
measures that reflect the core components of the COM-
PASS intervention. These include receipt of a follow-up
phone call within 2 business days, a clinic visit within 14
calendar days, a printed COMPASS-CP during the clinic
visit, and home health or outpatient rehabilitation services
within 30 days among those who were referred. We hope
the results of this pragmatic trial will provide evidence to
create national quality standards for post-acute stroke care
delivery, which currently do not exist.
In parallel to the pragmatic trial, and with supplemental
funding from the Wake Forest Clinical and Translational
Science Institute, we are conducting a comprehensive
process evaluation of the COMPASS care model
Fig. 3 COMPASS key messages - finding the way forward
Table 2 Patient-centered questions that informed design of the COMPASS care plan
Patient-centered question Incorporation into the COMPASS Care Plan (COMPASS-CP)
What are my health concerns? The COMPASS-CP template identifies health problems and concerns, both clinical and non-clinical, which could
influence health, independence, and recovery
Why is this important to me? The template explains the importance of each of the “problem” domains based on the results from the 4
assessments. COMPASS’s four dimensions of care are used to relay the importance of targeting the “problem”
domains during stroke recovery.
How do I find my way forward? Recommendations for patient self-management or referrals that are unique to the stroke survivors’ needs are
included, consistent with patient goals and preferences
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implementation guided by the RE-AIM Framework [49].
This analysis will evaluate the Reach, Adoption, Implemen-
tation, and Maintenance of the COMPASS intervention
while the pragmatic trial will evaluate Effectiveness. Efforts
to change clinical practice and deliver evidence-based pa-
tient care must be monitored and evaluated to inform
broader dissemination. We seek to advance implementa-
tion science by identifying individual, organizational, and
community factors affecting implementation of the
COMPASS care model. For the process evaluation, we will
use a mixed methods design. Data will include quantitative
data captured from bi-weekly questionnaires to the
hospital-based PAC teams that assess perceived barriers to
uptake and real-time data on enrollment and performance
measures. We will also use qualitative data obtained from
interviews with the implementation team and from
transcription and coding of bi-weekly phone calls with
PAC teams. These data, collected from intervention sites
over 1 year, will allow us to identify patient, staffing, and
community-level factors that impact intervention uptake,
pose challenges to uptake, and influence a health system’s
ability to improve performance on pre-defined perform-
ance measures.
Hospital training
All hospital staff were provided training on case
ascertainment, enrollment, study design and data quality.
Community providers at intervention sites also received
comprehensive training of the evidence-based COMPASS
care model. Training included site visits for all hospitals
and an intensive two-day centralized training “boot camp”
for PACs and APPs that equipped them for intervention
implementation. Ongoing support is provided with
monthly conference calls and distribution of hospital data
quality and performance reports that are reviewed with
sites monthly to highlight successes and processes that
need improvement.
Table 3 Domains assessed in post-discharge follow-up after stroke
Post-Discharge Follow-Up Call
• Medication reconciliation • Home Health/Outpatient Services
• New/Worsening Symptoms • Caregiver Assistance
• Falls • PCP follow-up Appointment
• Transportation • Stroke Clinic Follow-up appointment
Clinic Visit Post-Stroke Functional Assessment
• Medication Management • Spasticity
• Financials to Medication
Management
• Social Support
• Cognition • Physical Mobility & Safety
• Depression • General Health
• Health Literacy • Upper Extremity
• Access to PCP • Transportation
• ED/Hospital Readmissions • General health
• Status of Advance Directive • Falls
• Stress • ADL/IADL
Clinic Visit Caregiver Assessment
• Caregiver Assistance • Caregiver Stress
• Caregiver Health
Clinic Visit Advance Practice Provider Assessment
• Lifestyle Management (alcohol,
smoking, drugs,
• Risk factor management (blood
pressure, LDL, INR, HgA1c)
• Modified Rankin Scale • Depression
• Cognition • Communication
• Physical activity
Fig. 4 Generation of the patient individualized COMPASS care plan based on inputs from the clinic visit assessments
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Outcome assessment
Patient and caregiver outcomes are assessed over a
12-month follow-up period beginning at hospital dis-
charge. The primary outcome is patient functional status
90 days post-stroke discharge that assesses the degree to
which stroke-related impairments and disabilities affect
the patient’s functional status and quality of life [50]. The
SIS-16 is a self-reported questionnaire that can be com-
pleted by the patient or a proxy and was selected because
it is an outcome that matters to patients, their caregivers,
and stroke experts [51, 52]. The Modified Caregiver Strain
Index is collected from patient’s caregivers as a secondary
outcome [53]. We also assess a variety of secondary
patient outcomes using the telephone survey and adminis-
trative claims data (Table 4) [53–66]. All surveys are
available in English and Spanish.
Trained interviewers assess PROMs through a tele-
phone survey conducted approximately 90 days after
hospital discharge. Interviewers are blinded to treatment
group and use standardized scripts and interviewing
guidelines. We utilize reminder letters, additional phone
contacts, mailed surveys, and proxy interviews to
increase follow-up rates. Approximately 95 days after
patient’s hospital discharge, a self-administered survey is
mailed to the individual whom the patient had identified
as their primary caregiver. This survey includes the
Modified Caregiver Strain Index. If after 3 weeks a com-
pleted survey is not received, a reminder telephone call
and second mailing are administered. Health care
utilization data will be obtained from the CMS Medicare
and Medicaid administrative claims and from the North
Carolina Blue Cross/Blue Shield Health Insurance and
the State Health Care Plan data. These data include
claims for hospital visits, emergency department visits,
admissions to skilled nursing and inpatient rehabilitation
facilities, and hospital use of transitional management
billing codes.
Statistical considerations
Intention-to-treat analyses will be performed at the indi-
vidual level with adjustment for lack of independence
between hospitals. We will use a mixed model to
compare the primary endpoint (SIS-16, measured on a
continuous scale) between the COMPASS care model and
control groups. Although the stratified randomization of
hospitals should balance most important hospital-level
characteristics between groups, imbalances in patient-level
characteristics may exist. Therefore, the proposed mixed
model will include both fixed and random effects. The
primary analysis model will include two fixed effects,
randomization stratum (1 to 4) and intervention
(COMPASS care model vs. control), and one random
effect (hospital). Sample size and power calculations were
based on direct comparisons between the expected
changes in outcome means in the two groups, adjusted for
the intra-hospital correlation. With a sample size of 6000
recruited from 40 randomization units, we calculate that
we will have 83.2% power to detect a 4.17 unit difference
in the SIS-16 score for patients in the two groups (assum-
ing a standard deviation of 16.1) [50]. This assumes that
90% of patients will be evaluated at 90 days, an intra-class
correlation of 0.036 (based on preliminary data from
NCSCC hospitals), and a detectable effect of 0.192 times
the within-group standard deviation. The COMPASS
Study was also designed to detect differences within
subgroups of interest that comprise at least 20% of the
overall sample (e.g., stroke subtype, severity, insurance
status, geographic area of residence, race, and gender).
The intention-to-treat analyses will be complemented
with a treatment by protocol analysis, controlling for
Table 4 Secondary outcomes collected in the COMPASS Study
Patient self-reported outcomes Outcomes obtained from administrative claims data Caregiver self-reported outcomes
• General Health Measures • Hospital readmissions (30- and 90-day) • Modified Caregiver Strain Index
• Modified Rankin Scale (mRS) • Emergency department visits • Caregiver General Health Measure
• Physical Activity • Hospitalizations: Admissions and hospital days • Caregiver Support Services
• Patient Health Questionnaire (PHQ-2) • Skilled nursing facility use
• Montreal Cognitive Assessment (MoCA) 5-min protocol • Inpatient rehabilitation
• 4-Item Morisky Green Levine Scale
• Secondary Prevention Self-Management
• Usual care Provider Questions
• Use of Therapist services
• Falls and Hospitalizations
• PROMIS Fatigue Instrument
• Satisfaction with Care
• Use of Community Resources
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covariates that differ between those treated per protocol
(i.e., who received an individualized care plan) and
those who were not.
Informed consent
Because of the barriers to using traditional consent
methods in a cluster-randomized pragmatic trial design,
[67, 68] we used the broadcasting method. Patients are
notified about the study and allowed to ask questions, but
there is no option of opting out of participation in the
intervention other than seeking care at another hospital
[68]. By adopting this method, we minimized patient risk
and burden on clinical staff and maximized participation.
The COMPASS Study brochure included a way to opt out
of the research component (i.e., the 90-day survey). Verbal
consent was obtained at the beginning of the telephone
survey for the collection of those data.
Stakeholder engagement shaped the study design
Stakeholder engagement shaped our choice for a delayed
start design, which provided the best statistical control
to assess the intervention’s effects compared with
current practice, while also ensuring that all communi-
ties would benefit from the trial. Hospital stakeholders
(stroke and administrative leadership teams at 29 hospi-
tals) explicitly requested the opportunity to implement
the COMPASS care model at some point in the study
even if initially randomized to the control group. This
design feature supported our hospital recruitment ef-
forts. Patients and caregivers determined the primary
outcome, which measures aspects of physical function-
ing that matter to patients and their families, and is the
only widely used measure of stroke outcomes developed
from patient and caregiver focus groups [50, 51, 69].
Patients and caregivers also determined the selection of
our secondary outcome of caregiver strain. Stakeholders
helped develop the informed consent process (i.e.,
timing and language) and study materials. In addition, we
convened site-specific meetings with each intervention
hospital and their partners to engage local community
stakeholders, patients and caregivers and to orient them
to the study purpose, intervention and follow-ups, and
available learning modules. The community stakeholders
included primary care physicians, pharmacists, home
health agencies, outpatient rehab providers, Area Agency
on Aging representatives, faith leaders, emergency medicine
paramedics, and other community partners. Additional
information on our methods for engaging a broad
base of stakeholders are described elsewhere [70].
Discussion
This study was designed to evaluate whether implemen-
tation of a post-acute stroke care model in real-world
clinical practice improves functional status of stroke
patients discharged home compared with usual care.
Stroke is a high-cost, complex chronic disease that re-
quires extensive post-acute management. Comprehen-
sive post-acute services for stroke require bridging
hospital-based acute care with expanded care teams for
rehabilitation, primary care management, access to
community resources, and caregiver support. Early sup-
ported discharge and other transitions of care processes
may improve functional outcomes, but uncertainty re-
mains as to the best method to manage stroke patients
as they transition to home [26]. The CMS is setting new
directions and reimbursements for value-based care for
chronic conditions. Stroke may soon be targeted for
90-day bundled payments, which link payments for ser-
vices rendered during an episode of care encompassing
the inpatient stay and post-acute services through 90 days.
We have developed a multidisciplinary care model that
would meet these new standards.
A pragmatic trial addresses questions of effectiveness,
the degree of benefit of a given intervention tested in a
real-world setting. There is urgency for such information
to evaluate recommended transitional care and compre-
hensive services for stroke that can be readily imple-
mented into practice. The COMPASS Study will also
allow us to systematically evaluate the uptake of the
intervention in a diverse environment of hospital sys-
tems across North Carolina. At the same time, we
employed several strategies from a traditional trial de-
sign to measure adherence to the intervention, increase
participant retention, and standardize the capture of the
primary outcome in order to minimize selection bias. In
keeping with a pragmatic design, participants are
enrolled with few exclusion criteria and we believe this
will contribute to the generalizability of our findings to
stroke patients outside of North Carolina. We will be
assessing potential modifiers (e.g., age, race, sex, insur-
ance status, and stroke severity) and will consider these
in drawing inferences to different target populations.
Moreover, even though current post-acute care may
vary, our pragmatic care model incorporates this vari-
ability by tailoring the intervention to each community
and individual patient’s needs, connecting patients with
local resources. This adaptability further supports
generalizability of the COMPASS care model to other
clinical settings.
As part of our design, we chose to randomize the hos-
pital and not individual patients within a hospital. This
was deemed most appropriate given the system-level
nature of the intervention, which made patient-level
randomization within a single site not feasible. Group
randomization also allowed us to assess feasibility and
sustainability of implementing a new care model as the
new standard of care for a health system. The cluster-
randomized design however, may lead to imbalance in
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patient characteristics between randomization groups
due to the fewer number of randomization assignments.
The primary operational challenge in conducting the
study to date was navigating the complexity of rapidly
engaging diverse health systems for research. Hospitals
and systems were sometimes slow to engage because of
the substantial hospital investment of staff and other re-
sources needed to implement an intervention of this
scale. The financial support provided by the study is in
keeping with its pragmatic nature and is modest com-
pared with compensation offered in many traditional
clinical trials. Health systems have many competing pri-
orities and opportunities. The extensive engagement
challenges and solutions required to successfully recruit
a diverse mix of hospital systems is the topic of a future
publication. Initiating all hospitals simultaneously was
also a challenge. To address this we randomized and
launched sites in waves. This allowed us to direct separ-
ate implementation teams in a more focused manner to-
ward subsets of hospitals. This strategy also had the
unexpected benefit of allowing us more time to tailor
the intervention to each site and to conduct site-specific
visits and trainings in addition to the centralized training
sessions. Finally, use of a central IRB for streamlining
administrative burden was invaluable as was the rigorous
organizational structure needed to manage operations.
Conclusion
This trial addresses a critical gap in post-acute stroke care
management. If successful, the COMPASS care model,
which has been implemented into current clinical practice
in North Carolina, could be scaled to other settings, or tar-
geted for other chronic diseases, and would position health
systems for CMS value-based care models [40–43]. This
care model could be further expanded to engage primary
care and sub-specialty clinics which, in collaboration with
hospitals, would facilitate successful patient transitions to
health, independence, and recovery.
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